Matches in Wikidata for { <http://www.wikidata.org/entity/Q45143413> ?p ?o ?g. }
- Q45143413 description "2013 nî lūn-bûn" @default.
- Q45143413 description "2013年の論文" @default.
- Q45143413 description "2013年学术文章" @default.
- Q45143413 description "2013年学术文章" @default.
- Q45143413 description "2013年学术文章" @default.
- Q45143413 description "2013年学术文章" @default.
- Q45143413 description "2013年学术文章" @default.
- Q45143413 description "2013年学术文章" @default.
- Q45143413 description "2013年學術文章" @default.
- Q45143413 description "2013年學術文章" @default.
- Q45143413 description "2013年學術文章" @default.
- Q45143413 description "2013年學術文章" @default.
- Q45143413 description "2013年學術文章" @default.
- Q45143413 description "2013년 논문" @default.
- Q45143413 description "article científic" @default.
- Q45143413 description "article scientific" @default.
- Q45143413 description "article scientifique" @default.
- Q45143413 description "articol științific" @default.
- Q45143413 description "articolo scientifico" @default.
- Q45143413 description "artigo científico" @default.
- Q45143413 description "artigo científico" @default.
- Q45143413 description "artigo científico" @default.
- Q45143413 description "artikel ilmiah" @default.
- Q45143413 description "artikull shkencor" @default.
- Q45143413 description "artikulong pang-agham" @default.
- Q45143413 description "artykuł naukowy" @default.
- Q45143413 description "artículo científico publicado en 2013" @default.
- Q45143413 description "artículu científicu" @default.
- Q45143413 description "bilimsel makale" @default.
- Q45143413 description "bài báo khoa học" @default.
- Q45143413 description "naučni članak" @default.
- Q45143413 description "scienca artikolo" @default.
- Q45143413 description "scientific article published on 21 January 2013" @default.
- Q45143413 description "scientific article published on 21 January 2013" @default.
- Q45143413 description "scientific article published on 21 January 2013" @default.
- Q45143413 description "teaduslik artikkel" @default.
- Q45143413 description "tieteellinen artikkeli" @default.
- Q45143413 description "tudományos cikk" @default.
- Q45143413 description "vedecký článok" @default.
- Q45143413 description "vetenskaplig artikel" @default.
- Q45143413 description "videnskabelig artikel" @default.
- Q45143413 description "vitenskapelig artikkel" @default.
- Q45143413 description "vitskapeleg artikkel" @default.
- Q45143413 description "vědecký článek" @default.
- Q45143413 description "wetenschappelijk artikel" @default.
- Q45143413 description "wissenschaftlicher Artikel" @default.
- Q45143413 description "επιστημονικό άρθρο" @default.
- Q45143413 description "мақолаи илмӣ" @default.
- Q45143413 description "наукова стаття, опублікована в січні 2013" @default.
- Q45143413 description "научна статия" @default.
- Q45143413 description "научная статья" @default.
- Q45143413 description "научни чланак" @default.
- Q45143413 description "научни чланак" @default.
- Q45143413 description "գիտական հոդված հրատարակված 2013 թվականի հունվարի 21-ին" @default.
- Q45143413 description "מאמר מדעי" @default.
- Q45143413 description "مقالة علمية نشرت في 21 يناير 2013" @default.
- Q45143413 description "২১ জানুয়ারি ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q45143413 description "บทความทางวิทยาศาสตร์" @default.
- Q45143413 description "სამეცნიერო სტატია" @default.
- Q45143413 name "Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma" @default.
- Q45143413 name "Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma" @default.
- Q45143413 type Item @default.
- Q45143413 label "Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma" @default.
- Q45143413 label "Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma" @default.
- Q45143413 prefLabel "Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma" @default.
- Q45143413 prefLabel "Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma" @default.
- Q45143413 P1433 Q45143413-56FC0276-020E-4168-9CE5-8A79640AE360 @default.
- Q45143413 P1476 Q45143413-A875BE36-C38B-4FDE-BA8A-7BE4CD827011 @default.
- Q45143413 P2093 Q45143413-4620ABA0-20CE-4C8C-9004-24211B67C719 @default.
- Q45143413 P2093 Q45143413-4A862C2E-38E5-4942-BB64-04DCB89B4C2E @default.
- Q45143413 P2093 Q45143413-76F0E960-8DFB-4387-AA96-8DFAB484CC28 @default.
- Q45143413 P2093 Q45143413-7D15272A-D47F-478E-8152-51A4B06A27F1 @default.
- Q45143413 P2093 Q45143413-C0A582D3-CFF9-478D-A5AA-47F65FAE0E3E @default.
- Q45143413 P2093 Q45143413-C1902D2B-D740-405E-BD06-B339A35ED8E5 @default.
- Q45143413 P2093 Q45143413-C73A65F1-1A97-4411-A4B2-48BD88C19655 @default.
- Q45143413 P2093 Q45143413-CAB39486-8111-4C90-B7A7-240079226E39 @default.
- Q45143413 P2093 Q45143413-D55B220B-AD42-4E1A-B5BF-A4862C4676B1 @default.
- Q45143413 P304 Q45143413-89BCD20E-540B-41DB-B92F-22AC95696882 @default.
- Q45143413 P31 Q45143413-7A9135F1-2F1A-4862-BC5E-4C73C7511150 @default.
- Q45143413 P356 Q45143413-D3DB567B-72AE-4089-9476-ED0A323EEAC8 @default.
- Q45143413 P407 Q45143413-988D3F22-38D5-4CD2-A377-DC17BA9C157F @default.
- Q45143413 P433 Q45143413-FDE2D148-DFF8-4F37-A931-8849378F4248 @default.
- Q45143413 P478 Q45143413-B5B2AA2B-9DAB-4500-9948-795E55D44D04 @default.
- Q45143413 P50 Q45143413-5CE6D93C-ABA7-4F90-9E25-96A129CFD02D @default.
- Q45143413 P50 Q45143413-664CBE7B-5135-4401-873B-B796DE663D20 @default.
- Q45143413 P50 Q45143413-A9EB3DB7-A73B-40B9-A84C-F8E7AB5754CD @default.
- Q45143413 P577 Q45143413-C69E101B-D082-45A7-A218-E35FF726C332 @default.
- Q45143413 P698 Q45143413-471C1CB3-2189-48FF-A8C5-500F0360BED7 @default.
- Q45143413 P356 1078-0432.CCR-12-2885 @default.
- Q45143413 P698 23339124 @default.
- Q45143413 P1433 Q332253 @default.
- Q45143413 P1476 "Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma" @default.
- Q45143413 P2093 "Andrea Harzstark" @default.
- Q45143413 P2093 "Andrea Kay" @default.
- Q45143413 P2093 "Chia-Chi Lin" @default.
- Q45143413 P2093 "Daniel Castellano" @default.
- Q45143413 P2093 "Jose A Lopez-Martin" @default.
- Q45143413 P2093 "Julie Chang" @default.
- Q45143413 P2093 "Jürgen E Gschwend" @default.
- Q45143413 P2093 "Michael Shi" @default.